Coherus Oncology Inc (CHRS)

Operating Cash Flow Growth

-130.40%

TTM · Period ending:

CHRS logo

CHRS Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-130.40%
CHRS TTM Cash from Operations YoY % (-255.14% → -130.40%)
High-resolution chart · PNG

CHRS operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Coherus Oncology Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-130.4016%
-34,214.6%
-577.6566%
-45.5013%
-95.0764%
100.327%
88.3123%
76.3326%
77.8212%
40.2223%
27.4713%
-35.3537%
-71.4793%
-175.5278%
-544.1654%
-502.9929%
-274.7489%
-165.367%
-124.2836%
-65.3906%
-44.197%
43.7383%
443.6255%
477.8283%
208.8288%
154.0963%
117.8035%
74.1103%
4.3337%
-13.7441%
20.4807%
44.8701%
49.3865%
35.6356%
20.6929%
-60.6986%
-75.9844%
-64.9692%
-133.8596%
-9.0192%
-70.8512%
-110.84%
-351.3311%
-1,123.7172%
-325.0414%
-292.7038%
-255.1384%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.